Reporte de caso

Successful stem cell transplantation after nelarabine, pegylated asparaginase, vincristine, doxorubicin, and prednisone in refractory early T-cell precursor acute lymphoblastic leukemia: A case report

Back to article
Evolution of the patient's blood counts and medular blasts on admission and each treatment regimen.
AdmissionHyper-CVADClofarabineFLAG-IDANel Peg-Asp AdmVP
White blood cells [μl]56 7008800100015001000
Neutrophils [μl]23005500500100100
Lymphocytes [μl]15001600200825800
Monocytes [μl]0440000
Basophils [μl]0160000
Eosinophils [μl]001005850
Red Blood cells [μl]4 400 0003 000 0002 500 0002 600 0003 100 000
Hemoglobin [g/dL]13.69.67.68.29.2
Hematocrit [%]40.129.2212326.4
Platelets [μl]10512184026
Peripheral blasts [%]4230100
Medular Blasts [%]57.9361259.20

FLAG-IDA, fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin. Nel Peg-Asp AdmVP, nelarabine, pegylated-asparaginase, doxorubicin, vincristine, and prednisone. Hyper-CVAD, Hyperfractioned cyclophosphamide regimen in combination with, vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and dexamethasone.. μl, microliter. g/dL, grams per deciliter.

Source: Prepared by the authors, based on the patient's clinical history at Dávila Clinic.